Brief: Zynerba Pharmaceuticals reports Q2 results
10/08/2022 12:03
Aug 10 (Reuters) - Zynerba Pharmaceuticals Inc ZYNE.O :
* ZYNERBA PHARMACEUTICALS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
* $62.5 MILLION IN CASH AND CASH EQUIVALENTS AT JUNE 30,
2022;
CASH RUNWAY THROUGH END OF 2023 / EARLY 2024
* QTRLY NET LOSS PER SHARE - BASIC AND DILUTED $0.24
* Q2 EARNINGS PER SHARE VIEW $-0.23 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX344ZfS
Further company coverage: ZYNE.O
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary